Ovid Therapeutics
OVID
OVID
82 hedge funds and large institutions have $64.4M invested in Ovid Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 14 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
-9
Holders Change %
-9.89%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
40
Reduced
14
Closed
23
Calls
$205K
Puts
$703K
Net Calls
-$498K
Net Calls Change
-$793K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$2.08M |
| 2 |
Renaissance Technologies
New York
|
+$1.64M |
| 3 |
BlackRock
New York
|
+$1.51M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.34M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.81M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$6.3M |
| 3 |
AC
AWH Capital
Dallas,
Texas
|
-$1.29M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$779K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$695K |
